All Type of News
Domestic and multinational pharmaceutical companies are focusing on OTC drugs
In the pharmaceutical industry, it seems that investments on Over The Counter (OTC) medicines will get more popular. It was observed that companies are getting ready to concentrate on the OTC market in various ways.
...
Are non-stoppable multinational pharmaceutical companies so far stuck in difficult situations?
Multinational pharmaceutical companies are surrounded by serious issues. They have been non-stoppable in the pharmaceutical industry, but now they are getting pressured by different organizations.
First and foremost,...
The sudden increase of the breast cancer incidence, showing the highest rate in Easter Asia beyond JapanIt was discovered that the incidence of breast cancer in Korea has outran the one in Japan. Especially, it was shown that occurring type and current state of the disease has bee...
|
Desperation of multinational pharmaceutical companies on KRW 1 bid products
Multinational pharmaceutical companies are competing against domestic pharmaceutical companies in Korea to make contracts for KRW 1 bid products.
According to the industry concerned on the 17th, many companies, even ...
‘Promotion strategies using academic approaches’… Which companies showed up at the diabetes conference?
It is getting obvious on multinational pharmaceutical companies’ business strategies leaning towards academic aspects.
Korean Diabetes Association held an autumn academic conference at the Ilsan Kintex, scheduled for...
‘Frustration’ of doctors seeing the beneficial restriction over Umckamin SyrupWhile pharmaceutical companies are opposing to the beneficial restriction of an antitussive expectorant, Umckamin Syrup, clinical institutions has also criticized about the issu...
|
.jpg)
After the end of the conflict between the pharmaceutical distribution companies and GSK, multinational pharmaceutical companies has suddenly changed their attitudes
After the end of the conflict between GlaxoSmithKline (GSK) and the pharmaceutical distribution companies, multinational pharmaceutical companies are starting to change their attitudes.
Changes in their existing poli...
The number of Korean pharmaceutical companies’ patent applications reaches only up to 18%of what multinational companies have
It was shown that the ratio of Korean pharmaceutical companies’ patent applications against multinational pharm companies is less than 20%.
According to the ‘patent application survey of domestic pharmaceutical compa...
LG Life Science’s partnership for the ‘Humira biosimilar’ with Mochida in Japan
On the 15th, LG Life Science Ltd. (CEO: Il-jae Jung) announced that it made a partnership with a Japanese company, Mochida, to develop and sell the Humira biosimilar, a global drug for autoimmune disease.
Through the...
A strategy to own twin drugs through Korean domestic branches spreads in the pharmaceutical industry
Korean pharmaceutical companies owning original medicines are getting ready for the patent expirations in various ways, too.
Several companies are implementing a strategy to commercialize twin medicines with the same...
